Article Versions Notes

Schöffski P, Guillem V, Garcia M, Rivera F, Tabernero J, Cullell M, Lopez-Martin JA, Pollard P, Dumez H, Garcia del Muro X, et al. Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma. Marine Drugs. 2009; 7(1):57-70. https://doi.org/10.3390/md7010057

Schöffski, Patrick, Vincente Guillem, Margarita Garcia, Fernando Rivera, Josep Tabernero, Martin Cullell, Jose Antonio Lopez-Martin, Patricia Pollard, Herlinde Dumez, Xavier Garcia del Muro, and et al. 2009. "Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma" Marine Drugs 7, no. 1: 57-70. https://doi.org/10.3390/md7010057

Schöffski, P., Guillem, V., Garcia, M., Rivera, F., Tabernero, J., Cullell, M., Lopez-Martin, J. A., Pollard, P., Dumez, H., Garcia del Muro, X., & Paz-Ares, L. (2009). Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma. Marine Drugs, 7(1), 57-70. https://doi.org/10.3390/md7010057